J. Su

发表

A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival.

Yi-long Wu, Jin-Ji Yang, Chao Zhang, 2022, Lung cancer.

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients

X. Yi, C. Deng, Yi-long Wu, 2020, Thoracic cancer.

Polymorphism of Rs9387478 Correlates with Overall Survival in Female Nonsmoking Patients with Lung Cancer

N. Rothman, Yi-long Wu, Jin-Ji Yang, 2016, The International journal of biological markers.

The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis

M. Zhan, F. Jiang, J. Liao, 2015, Oncotarget.

Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma.

Yi-long Wu, Jin-Ji Yang, Chao Zhang, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Jian Su, Qing Zhou, Hai-Yan Tu, 2016, Clinical Cancer Research.

Soluble c‐Met Levels Correlated With Tissue c‐Met Protein Expression in Patients With Advanced Non–Small‐Cell Lung Cancer

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2017, Clinical lung cancer.

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

X. Yi, Yi-long Wu, W. Zhong, 2020, EBioMedicine.

Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies

Yi-long Wu, Jin-Ji Yang, Chao Zhang, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

Yi-long Wu, Chao Zhang, W. Zhong, 2017, Oncoimmunology.

Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Yi-long Wu, Jin-Ji Yang, S. Chuai, 2017, Clinical Cancer Research.

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

Ying Cheng, Yi-long Wu, Jin-Ji Yang, 2021, Nature Communications.

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women.

X. Hua, Jianxin Shi, Y. Miyagi, 2019, Genomics.

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Ping Wang, Junjie Wu, Jian Su, 2016, Human molecular genetics.

Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women.

Hongbing Shen, Chien-Jen Chen, N. Rothman, 2016, Human molecular genetics.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

Jian Su, Wen Tan, Paolo Vineis, 2015, Journal of the National Cancer Institute.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Alison P. Klein, William Wheeler, Li Jin, 2015 .

Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

B. Qian, Hongbing Shen, Chien-Jen Chen, 2012, Nature Genetics.

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

Jin-Ji Yang, Chongrui Xu, Xuchao Zhang, 2023, Cell reports. Medicine.

Clinical outcomes of EGFR +/ METamp+ vs. EGFR +/ METamp‐ untreated patients with advanced non‐small cell lung cancer

Jin-Ji Yang, Xuchao Zhang, Jian Su, 2022, Thoracic cancer.

Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.

T. Mok, Yi-long Wu, Jin-Ji Yang, 2010, Clinical lung cancer.

Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules

Jing Qin, Yi-long Wu, Jin-Ji Yang, 2019, Journal of extracellular vesicles.

Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2011, European journal of cancer.

Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2011, Chinese medical journal.

Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score

Yi-long Wu, Jin-Ji Yang, K. Yin, 2021, Translational oncology.

Restriction Landmark Genomic Scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations

R. Wenger, Yue-zhong Wu, C. Plass, 2007, BMC Genomics.

Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers

X. Yi, Xue-Ning Yang, W. Zhong, 2022, Thoracic cancer.

Genomic Signatures Define Three Subtypes of EGFR-Mutant Stage II-III NSCLC With Distinct Adjuvant Therapy Outcomes

W. Mao, Ying Cheng, Yi-long Wu, 2021 .

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer

F. Jiang, Yanli Lin, Q. Leng, 2018, Biomarkers in cancer.

Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2015, Journal of Hematology & Oncology.

Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees

Yi-long Wu, W. Zhong, Gong Zhang, 2020, BMC Cancer.

Sputum microRNA Biomarkers for Identifying Lung Cancer in Indeterminate Solitary Pulmonary Nodules

Jian Su, Feng Jiang, F. Jiang, 2015, Clinical Cancer Research.

Network-based analysis reveals distinct association patterns in a semantic MEDLINE-based drug-disease-gene network

Asha A. Nair, C. Chute, Hongfang Liu, 2014, J. Biomed. Semant..

Timing and origins of local and distant metastases in lung cancer.

Yi-long Wu, W. Zhong, Yang Xu, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer

T. Mok, Yi-long Wu, Xuchao Zhang, 2009, Pathology & Oncology Research.

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2017, Lung cancer.

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2020, Frontiers in Oncology.

Anaplastic Lymphoma Kinase Variants and the Percentage of ALK-Positive Tumor Cells and the Efficacy of Crizotinib in Advanced NSCLC.

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2016, Clinical lung cancer.

Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancer.

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2015, Lung cancer.

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2021, Experimental Hematology & Oncology.

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

Yi-long Wu, S. An, Xuchao Zhang, 2016, PloS one.

Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2016, Thoracic cancer.

KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2013, Annals of Surgical Oncology.

Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2015, Clinical lung cancer.

A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2013, Lung cancer.

Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

T. Mok, Yi-long Wu, Jin-Ji Yang, 2012, PloS one.

The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2016, Oncotarget.

Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901).

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2020, Clinical lung cancer.

Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study.

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2020, Lung cancer.

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Jian Su, Jun Zhao, Qing Zhou, 2018, BMC Cancer.

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma

Jin-Ji Yang, Yilong Wu, Chongrui Xu, 2016, Oncotarget.

Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome Sequencing.

Yi-long Wu, Jin-Ji Yang, Y. Lei, 2015, Journal of genetics and genomics = Yi chuan xue bao.

A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805).

Ying Cheng, Yi-long Wu, Jin-Ji Yang, 2014, Lung cancer.

Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer.

Yi-long Wu, S. An, Xuchao Zhang, 2012, Experimental and therapeutic medicine.

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2016, Journal of Hematology & Oncology.

EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

T. Mok, Yi-long Wu, Jin-Ji Yang, 2012, The oncologist.

Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

Jin-Ji Yang, Yilong Wu, Chongrui Xu, 2019, BMC Cancer.

Lung Cancers with Concomitant EGFR Mutations and ALK Rearrangements: Diverse Responses to EGFR-TKI and Crizotinib in Relation to Diverse Receptors Phosphorylation

T. Mok, Yi-long Wu, Jin-Ji Yang, 2014, Clinical Cancer Research.

Disease Flare After EGFR Tyrosine Kinase Inhibitor Cessation Predicts Poor Survival in Patients with Non-small Cell Lung Cancer

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2013, Pathology & Oncology Research.

Familial association of lung cancer with liver cancer in first-degree relatives

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2019, Cancer management and research.

Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer.

Yi-long Wu, W. Zhong, M. Cheng, 2020, Cancer treatment and research communications.

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer consortium in Asia

B. Qian, Hongbing Shen, Chien-Jen Chen, 2015, International journal of cancer.

Single Nucleotide Polymorphisms in VTI1A Gene Contribute to the Susceptibility of Chinese Population to Non-Small Cell Lung cancer

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2015, The International journal of biological markers.

Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers.

Jin-Ji Yang, Xue-Ning Yang, W. Zhong, 2015, Lung cancer.

Stromal PD‐L1–Positive Regulatory T cells and PD‐1–Positive CD8‐Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD‐1/PD‐L1 Blockade Immunotherapy

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay

Yi-long Wu, W. Zhong, S. An, 2014, Chinese journal of cancer.

BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2013, Molecular Cancer.

P1.01-018 Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression

Jin-Ji Yang, W. Zhong, Z. Xie, 2017 .

Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer.

Yi-long Wu, W. Zhong, Hong-Hong Yan, 2017, The oncologist.

The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer

Jian Su, Jia-Ying Lin, Yi-long Wu, 2009, BMC Cancer.

Sputum long non-coding RNA biomarkers for diagnosis of lung cancer.

M. Zhan, F. Jiang, S. Stass, 2019, Cancer biomarkers : section A of Disease markers.

Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

Yi-long Wu, Chao Zhang, Xue-Ning Yang, 2021, Journal for ImmunoTherapy of Cancer.

Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2018, Lung cancer.

Establishment and application of a method of next generation sequencing of 285 genes in lung cancer based on Ion-Proton platform

Xuchao Zhang, Zhi-hong Chen, Wei-bang Guo, 2020, Translational cancer research.

Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease.

J. Zhuang, Jian Su, Zhi-hong Chen, 2010, The Annals of thoracic surgery.

Gene Transfer of Calcitonin Gene-Related Peptide Inhibits Macrophages and Inflammatory Mediators in Vein Graft Disease

J. Zhuang, Jian Su, Zhi-hong Chen, 2008 .

MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation

Yi-long Wu, S. An, Jian Su, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third‐Generation EGFR Tyrosine Kinase Inhibitor Osimertinib

Yi-long Wu, Jin-Ji Yang, Z. Wang, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2019, EBioMedicine.

Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC).

Yi-long Wu, Xue-Ning Yang, S. An, 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2017, Clinical Cancer Research.

Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2012, Medical Oncology.

TNM stages inversely correlate with the age at diagnosis in ALK-positive lung cancer.

Chao Zhang, Xue-Ning Yang, W. Zhong, 2019, Translational lung cancer research.

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

L. Kiemeney, Y. Miyagi, B. Qian, 2023, Nature communications.

Sintilimab versus pembrolizumab in monotherapy or combination with chemotherapy as first-line therapy for advanced non–small cell lung cancer: Results from phase 2, randomized clinical trial (CTONG1901).

Jin-Ji Yang, Xuchao Zhang, Hong-Hong Yan, 2022, Journal of Clinical Oncology.

Clinical outcomes of EGFR +/ MET amp + vs. EGFR +/

Jin-Ji Yang, Xuchao Zhang, Jian Su, 2022, Thoracic Cancer.

Analysis of Lung Flute–collected Sputum for Lung Cancer Diagnosis

F. Jiang, S. Stass, Maria A. Guarnera, 2015, Biomarker insights.

Heterogeneous responses and resistant mechanisms to crizotinib in ALK‐positive advanced non‐small cell lung cancer

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2018, Thoracic cancer.

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2018, BMC Cancer.

Accidental invisible intrathoracic disseminated pT4-M1a: a distinct lung cancer with favorable prognosis.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2015, Journal of thoracic disease.

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2016, Oncotarget.

Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2017, Oncotarget.

Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk

Yi-long Wu, Chao Zhang, Xue-Ning Yang, 2021, Translational lung cancer research.

Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level

Jin-Ji Yang, Yilong Wu, Chongrui Xu, 2019, BMC Cancer.

Clinical Utility of Cerebrospinal Fluid Cell‐Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK‐Rearranged NSCLC

Yi-long Wu, Jin-Ji Yang, S. Chuai, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.

Yi-long Wu, Xuchao Zhang, Jian Su, 2015, Journal of thoracic disease.

Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival

Yi-long Wu, Xue-Ning Yang, W. Zhong, 2020, Annals of Surgical Oncology.

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

Yi-long Wu, Xue-Ning Yang, W. Zhong, 2017, British Journal of Cancer.

Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer

Chao Zhang, W. Zhong, H. Bao, 2023, Oncoimmunology.

Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers.

Jin-Ji Yang, Xue-Ning Yang, W. Zhong, 2015, Lung Cancer.

变性高效液相色谱法检测多种途径获取的非小细胞肺癌组织表皮生长因子受体基因突变

Jin-Ji Yang, Xue-Ning Yang, Yilong Wu, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

Chongrui Xu, Q. Gou, Hong-Hong Yan, 2023, Journal for ImmunoTherapy of Cancer.

Familial association of lung cancer with liver cancer in ﬁ rst-degree relatives

Jin-Ji Yang, Xuchao Zhang, Yi-sheng Huang, 2019 .

Sputum microRNA Biomarkers for Identifying Lung Cancer in Indeterminate Solitary Pulmonary Nodules

F. Jiang, S. Stass, Maria A. Guarnera, 2015, Clinical Cancer Research.

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)

Xue-Ning Yang, Chongrui Xu, Li-xu Yan, 2024, Cell Reports Medicine.

Network-based analysis reveals distinct association patterns in a semantic MEDLINE-based drug-disease-gene network

Jian Su, Cui Tao, Hongfang Liu, 2014, Journal of Biomedical Semantics.

MET Expression Plays Differing Roles in Non–Small-Cell Lung Cancer Patients with or without EGFR Mutation

Yi-long Wu, S. An, Zhi-hong Chen, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.